p35/Cdk5 pathway mediates soluble amyloid‐β peptide‐induced tau phosphorylation in vitro

Journal of Neuroscience Research - Tập 69 Số 3 - Trang 362-372 - 2002
Terrence Town1, Joseph Zolton, Reed Shaffner, Billy Schnell, Robert M. Crescentini, Yajuan Wu, Jin Zeng, Anthony DelleDonne, Demian Obregon, Jun Tan, Michael Mullan
1The Roskamp Institute, Department of Psychiatry, University of South Florida, Tampa 33613, USA.

Tóm tắt

AbstractAlzheimer's disease (AD) is pathologically characterized by deposition of amyloid‐β peptides (Aβ) as senile plaques and by the occurrence of neurofibrillary tangles (NFTs) composed primarily of hyperphosphorylated tau protein. Activation of cyclin‐dependent kinase 5 (Cdk5) via its potent activator p25 has recently been shown to promote phosphorylation of tau at AD‐specific phosphoepitopes, and increased cleavage of p35 to p25 has been demonstrated in AD patients, suggesting that Cdk5 may represent a pathogenic tau protein kinase. We were interested in the potential effect of soluble forms of Aβ on Cdk5‐mediated AD‐like tau phosphorylation, insofar as previous studies of human biopsies and aged canine and primate brains have shown that dystrophic neurites appear before the formation of neuritic plaques. We transfected N2a cells with a p35 vector (N2a/p35 cells) and, after differentiation, challenged these cells with Aβ1–42 peptide in soluble form (sAβ1–42). Results show that sAβ1–42 at relatively low levels (1–5 μM) dose‐dependently increases tau phosphorylation at AD‐specific phosphoepitopes in differentiated N2a/p35 cells compared with controls, an effect that is blocked by antisense oligonucleotides against p35. sAβ1–42‐induced tau phosphorylation is concomitant with an increase in both p25 to p35 ratio and Cdk5 activity (but not protein levels). Additionally, blockade of L‐type calcium channels or inhibition of calpain completely abolishes this effect. Taken together, these data indicate that sAβ is a potent activator of the p25/Cdk5 pathway, resulting in promotion of AD‐like tau phosphorylation in vitro. © 2002 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1006/excr.2001.5152

10.1073/pnas.78.2.1237

10.1007/978-3-7091-6467-9_11

10.1016/0304-3940(96)12668-9

10.1083/jcb.103.6.2739

10.1002/1097-4547(20001101)62:3<463::AID-JNR16>3.0.CO;2-7

10.1016/S0304-3940(98)00054-8

10.1073/pnas.83.13.4913

10.1046/j.1471-4159.1999.0720206.x

10.1042/bj3010871

10.1016/S0925-4439(00)00038-7

10.1016/0896-6273(88)90129-8

10.1074/jbc.M002466200

10.1038/35012636

10.1073/pnas.89.12.5384

10.1046/j.1471-4159.2001.00130.x

Martin LJ, 1994, Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex, Am J Pathol, 145, 1358

10.1016/0006-8993(92)90323-2

10.1523/JNEUROSCI.12-02-00376.1992

10.1054/mehy.1997.0680

10.1007/BF00227819

10.1073/pnas.65.1.129

10.1523/JNEUROSCI.18-23-09858.1998

10.1038/45159

10.1097/00001756-199908020-00035

10.1002/1097-4547(20000715)61:2<128::AID-JNR2>3.0.CO;2-H

10.1021/bi981874p

10.1016/S0168-0102(98)00061-3

10.1016/S0304-3940(01)01864-X

Tan J, 1999, Ligation of microglial CD40 results in p44/42 mitogen‐activated protein kinase‐dependent TNF‐alpha production that is opposed by TGF‐beta1 and IL‐10, J Immunol, 163, 6614, 10.4049/jimmunol.163.12.6614

10.1002/9780470719749.ch10

10.1016/S0304-3940(00)01767-5

10.1093/emboj/18.1.109

10.1006/nbdi.2000.0333

10.1016/S0197-4580(98)00071-2

10.1006/exnr.1999.7085

Wisniewski H, 1970, Senile plaques and cerebral amyloidosis in aged dogs. A histochemical and ultrastructural study, Lab Invest, 23, 287

10.1097/00005072-197310000-00007

10.1046/j.1471-4159.2000.0752346.x

10.1093/jnen/59.10.880

Thông tin
Thông tin xuất bản

Journal of Neuroscience Research

Tập 69 Số 3

362-372

Thông tin tác giả